| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.42 | 0.02 |